These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 12594630

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combination hormone therapy tied to slight increase in breast cancer deaths.
    Mayo Clin Womens Healthsource; 2011 Mar; 15(3):3. PubMed ID: 21301403
    [No Abstract] [Full Text] [Related]

  • 4. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
    Twombly R.
    J Natl Cancer Inst; 2007 Dec 19; 99(24):1828-9, 1835. PubMed ID: 18073368
    [No Abstract] [Full Text] [Related]

  • 5. Women seek alternatives to hormone replacement therapy.
    Altern Ther Health Med; 2002 Dec 19; 8(5):27. PubMed ID: 12233798
    [No Abstract] [Full Text] [Related]

  • 6. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice.
    Obstet Gynecol; 2008 Nov 19; 112(5):1189-92. PubMed ID: 18978127
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hormone therapy's unanswered questions.
    Harv Womens Health Watch; 2004 Jul 19; 11(11):1. PubMed ID: 15273055
    [No Abstract] [Full Text] [Related]

  • 10. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
    Harv Womens Health Watch; 2002 Oct 19; 10(2):2-4. PubMed ID: 12393317
    [No Abstract] [Full Text] [Related]

  • 11. Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.
    Murkes D, Conner P, Leifland K, Tani E, Beliard A, Lundström E, Söderqvist G.
    Fertil Steril; 2011 Mar 01; 95(3):1188-91. PubMed ID: 21067727
    [Abstract] [Full Text] [Related]

  • 12. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR, TREAT.
    Maturitas; 2005 Sep 16; 52(1):1-10. PubMed ID: 15963666
    [Abstract] [Full Text] [Related]

  • 13. Hormone therapy. A year in review.
    Mayo Clin Womens Healthsource; 2003 Aug 16; 7(8):1-2. PubMed ID: 12925832
    [Abstract] [Full Text] [Related]

  • 14. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
    Romero M.
    Adv Nurse Pract; 2002 Nov 16; 10(11):47-8, 51-2. PubMed ID: 12478948
    [No Abstract] [Full Text] [Related]

  • 15. Women's health. The vanishing promises of hormone replacement.
    Enserink M.
    Science; 2002 Jul 19; 297(5580):325-6. PubMed ID: 12130763
    [No Abstract] [Full Text] [Related]

  • 16. Pfizer ordered to pay $103m over hormone drugs and breast cancer.
    Tanne JH.
    BMJ; 2009 Nov 27; 339():b5085. PubMed ID: 19946002
    [No Abstract] [Full Text] [Related]

  • 17. Estrogen research. Brain researchers try to salvage estrogen treatments.
    Wickelgren I.
    Science; 2003 Nov 14; 302(5648):1138-9. PubMed ID: 14615509
    [No Abstract] [Full Text] [Related]

  • 18. Do risks of hormone therapy persist after discontinuation?
    J Fam Pract; 2008 Jun 14; 57(6):366, 369. PubMed ID: 18677802
    [No Abstract] [Full Text] [Related]

  • 19. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
    Stjernquist M, North American Menopause Society (NAMS) Advisory Panel.
    Lakartidningen; 2003 May 15; 100(20):1790-7. PubMed ID: 12806859
    [Abstract] [Full Text] [Related]

  • 20. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun 15; 13(71):106-9. PubMed ID: 15233153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.